Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO

SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets 

Pressure Biosciences : Pressure BioSciences, Inc. to Present at the Rodman & Renshaw 8th Annual Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/02/2006 | 09:15am EDT

Pressure BioSciences, Inc. (NASDAQ: PBIO) today announced that it will present at the Rodman & Renshaw 8th Annual Healthcare Conference to be held at the New York Palace Hotel, New York, NY on November 6-8, 2006. Mr. Richard T. Schumacher, PBI President and CEO, will give a corporate overview at 9:55 am (EST) on Wednesday, November 8th. Investors will be able to hear the presentation starting on November 8th and for approximately 90 days thereafter at http://www.wsw.com/webcast/rrshq10/pbio/.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded, early-stage company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 5 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-QSB for the quarter ended June 30, 2006, in the Company's Annual Report on Form 10-KSB, as amended, for the year ended December 31, 2005, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

Visit us at our website http://www.pressurebiosciences.com


© Business Wire 2006
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PRESSURE BIOSCIENCES, INC.
04/24 PRESSURE BIOSCIENCES INC : Entry into a Material Definitive Agreement, Creation ..
04/17 PRESSURE BIOSCIENCES, INC. : Appoints Joseph L. Damasio Jr. as Vice President of..
04/14 PRESSURE BIOSCIENCES, INC. (OTCMKTS : PBIO) Files An 8-K Departure of Directors ..
04/14 PRESSURE BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K)
03/29 PRESSURE BIOSCIENCES INC : WallStreet Research(TM) Announces Availability of Upd..
03/23 PRESSURE BIOSCIENCES, INC. : Significantly Expands Marketing and Sales Capabilit..
03/22 PRESSURE BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
03/22 PRESSURE BIOSCIENCES, INC. : Reports Fourth Quarter and Fiscal Year 2016 Financi..
03/22 PRESSURE BIOSCIENCES : Reports Fourth Quarter and Fiscal Year 2016 Financial Res..
03/21 PRESSURE BIOSCIENCES, INC. : to Discuss Fourth Quarter and Fiscal Year 2016 Fina..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
04/24DJWHAT'S NEWS : Business & Finance -- WSJ
04/23 Becton Dickinson to acquire Bard for $24 billion
04/23DJBECTON DICKINSON AND : to Acquire C.R. Bard for $24 Billion
04/19DJCardinal Swoops In, Strikes Deal -- WSJ
04/18DJCARDINAL HEALTH : $6.1 Billion Deal for Some Medtronic Operations Raises Debt Co..
More sector news : Medical Equipment, Supplies & Distribution - NEC
Advertisement
Managers
NameTitle
Richard T. Schumacher President, CEO, Secretary & Treasurer
Jeffrey N. Peterson Chairman
Joseph Luis Damasio Chief Financial Officer & VP-Finance
Edmund Y. Ting Senior Vice President-Engineering
Vito J. Mangiardi Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PRESSURE BIOSCIENCES, ..9
MEDTRONIC PLC13.22%110 401
BAXTER INTERNATIONAL I..20.55%28 968
ZIMMER BIOMET HOLDINGS..19.45%24 805
C R BARD INC34.61%21 868
HOYA CORPORATION4.45%18 181
More Results